Mercachem Holding bv:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mercachem Holding bv - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10904
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mercachem Holding BV (Mercachem) is a research company that offers transparent chemistry services. The company provides services in the areas of discovery chemistry, medicinal chemistry, parallel chemistry and process research. Its parallel chemistry services include library design, chemical validation, library synthesis and purification services. Mercachem’s process research services comprise route scouting, reaction optimization, catalyst screening, GMP production and impurity research. The company also offers optimization of lead molecules towards clinical candidates. It operates through its synthesis laboratories and analytical facility in the Netherlands. Mercachem is headquartered in Nijmegen, the Netherlands.

Mercachem Holding bv – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mercachem Holding bv, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 10
Partnerships 11
AiCuris Anti-infective Cures and Mercachem Enter into Research Agreement 11
Mercachem Forms Joint Venture with UbiQ Bio 12
Almirall Enters into Research Agreement with Mercachem 13
Mercachem Enters into Research Agreement with NB Health Lab 14
ProQinase Enters Into Co-Development Agreement With Mercachem For Drug Discovery Platform 15
Merger 16
Mercachem and Syncom Merge 16
Mercachem Holding bv – Key Competitors 17
Mercachem Holding bv – Key Employees 18
Mercachem Holding bv – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Mercachem Holding bv, Pharmaceuticals & Healthcare, Key Facts 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mercachem Holding bv, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mercachem Holding bv, Deals By Therapy Area, 2012 to YTD 2018 8
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 10
AiCuris Anti-infective Cures and Mercachem Enter into Research Agreement 11
Mercachem Forms Joint Venture with UbiQ Bio 12
Almirall Enters into Research Agreement with Mercachem 13
Mercachem Enters into Research Agreement with NB Health Lab 14
ProQinase Enters Into Co-Development Agreement With Mercachem For Drug Discovery Platform 15
Mercachem and Syncom Merge 16
Mercachem Holding bv, Key Competitors 17
Mercachem Holding bv, Key Employees 18
Mercachem Holding bv, Subsidiaries 19
Mercachem Holding bv, Joint Venture 19

List of Figures
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Mercachem Holding bv:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nevro Corp (NVRO):医療機器:M&Aディール及び事業提携情報
    Summary Nevro Corp (Nevro) is a medical device company that offers products for the treatment of chronic pain. The company develops and commercializes senza spinal cord stimulation system (SCS), an evidence-based neuromodulation platform. Its solution for chronic pain also includes HF10 Therapy, whi …
  • China Grand Pharmaceutical and Healthcare Holdings Ltd (512)-医療機器分野:企業M&A・提携分析
    Summary China Grand Pharmaceutical and Healthcare Holdings Ltd (China Grand) is an investment holding company that develops, manufacture and distributes pharmaceutical preparations, medical devices and pharmaceutical intermediates, specialized raw materials, and healthcare products. The company’s pr …
  • Southern Co (SO):電力:M&Aディール及び事業提携情報
    Summary Southern Co is a gas and electric utility holding company. It generates, distributes, markets and trades electricity and distributes gas. It uses a variety of sources for electricity generation including coal, oil and gas, nuclear and hydro. The company also distributes natural gas through t …
  • Qatar Petroleum:企業のM&A・提携動向(エネルギー分野)
    Summary Qatar Petroleum (QP) is a state-owned oil and gas company. The company, along with subsidiaries, affiliates and joint ventures, undertake the exploration, drilling, production, storage, transportation, marketing and sale of crude oil, natural gas and gas liquids, liquefied natural gas (LNG), …
  • GI Dynamics, Inc. (GID):企業のM&A・提携動向(医療機器分野)
    Summary GI Dynamics, Inc. (GI Dynamics) is a medical service provider that develops and commercializes non-surgical treatments for patients. The company’s product includes EndoBarrier therapy. Its product EndoBarrier is an endoscopically delivered device therapy that is designed to mimic the mechani …
  • NTR plc:企業のM&A・提携動向(エネルギー分野)
    Summary NTR plc (NTR) is a renewable investment and asset management company. It invests in wind energy projects the UK and Ireland and also looks for opportunities in other European countries for future wind project investments. NTR provides operations and maintenance solutions for water infrastruc …
  • Origin Agritech Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Origin Agritech Limited Mergers …
  • Kawasaki Heavy Industries, Ltd. (7012):企業のM&A・提携動向(石油・ガス分野)
    Summary Kawasaki Heavy Industries, Ltd. (KHI) is a manufacturer of transportation equipment and industrial goods. The company’s product portfolio includes liquefied natural gas (LNG) carriers, liquefied petroleum gas (LPG) carriers, container ships, bulk carriers, electric and diesel locomotives, pa …
  • Academic Medical Center:企業のM&A・提携動向(医療分野)
    Summary Academic Medical Center (AMC) is a medical centre that offers research and educational services. The centre offers services such as treatment of patients, medical research and medical education. It provides medical treatments and services for various category of disease. AMC’s research areas …
  • CNA Financial Corporation:企業の戦略・SWOT・財務情報
    CNA Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary CNA Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • VBI Vaccines Inc (VBIV):企業のM&A・提携動向(医療分野)
    Summary VBI Vaccines Inc (VBI), formerly SciVac Therapeutics Inc., discovers and develops novel vaccines for the treatment of infectious diseases and immuno-oncology. It offers Sci-B-Vac, a hepatitis B vaccine which mimics all the three viral surface antigens of hepatitis B virus. The company’s port …
  • Ensign Energy Services Inc. (ESI):企業のM&A・提携動向(石油・ガス分野)
    Summary Ensign Energy Services Inc. (Ensign Energy) is an energy services company that provides oilfield services. The company’s services include drilling, directional drilling, testing and well servicing. It offers drilling services for oil, oil sands, natural gas, coal bed methane and geothermal r …
  • Alexza Pharmaceuticals Inc:企業の戦略的SWOT分析
    Alexza Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Keryx Biopharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Keryx Biopharmaceuticals, Inc. …
  • National Research Council of Canada:企業のM&A・事業提携・投資動向
    National Research Council of Canada - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Research Council of Canada Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • ScanSource Inc (SCSC):企業の財務・戦略的SWOT分析
    ScanSource Inc (SCSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Shandong Luoxin Pharmacy Stock Co., Ltd. (8058):企業の財務及び戦略的SWOT分析
    Summary Shandong Luoxin Pharmacy Stock Co., Ltd. (Shandong Luoxin) is a pharmaceutical company. The company develops, manufactures and markets drugs. Its products include digestive system drugs, respiratory drugs, antineoplastic, anti-tumor adjuvant, antiviral drugs, circulatory system drugs, nervou …
  • Adamis Pharmaceuticals Corp (ADMP):企業財務及び戦略的SWOT分析
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals, Inc., is a specialty biopharmaceutical company that develops and commercializes products in the therapeutic areas of allergy and respiratory diseases. Its lead pipeline product, Epinephrine Pre-filled Syringe (PFS) is de …
  • XDx, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' XDx, Inc. Mergers and Acquisiti …
  • China Shipbuilding Industry Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' China Shipbuilding Industry Cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆